SeriesUnderstanding the mechanisms and drivers of antimicrobial resistance
Introduction
The increasing challenge to health care attributable to antimicrobial resistance, and the subsequent absence of access to effective antimicrobials, is of worldwide concern. There is a real threat that the public health gains from improved access to antimicrobials, including the improvements in childhood survival, could be undermined.1 Understanding the scientific basis of antimicrobial resistance is essential to combating this public health threat. This understanding should cover the resistance mechanisms, enabling novel approaches to diagnostics and therapeutics, through to the drivers of antimicrobial resistance in society and the environment, essential for the development of appropriate interventional policies.2, 3, 4 The many factors contributing to the present worldwide status of antimicrobial resistance are reviewed in this Series paper, with a particular focus on emergence of resistance, transmission, bacterial fitness, and potential for reversibility. The evidence for, and the role of, important drivers of antimicrobial resistance are considered and assessed in the context of the community (including the environment and agriculture) and in health-care systems. Please see appendix for a list of supplementary references. From this evidence, stakeholders can engage with issues specific to their area of practice, yet also be mindful of cross-sectoral interconnectivity and the need for a One Health approach to antimicrobial resistance.
Section snippets
Why does resistance emerge within a micro-organism?
Through a darwinian selection process microorganisms have developed robust mechanisms to evade destruction from many toxic substances. Most antimicrobial drugs are naturally produced by microorganisms, including environmental fungi and saprophytic bacteria, or are synthetic modifications of them, with only a few drugs (eg, sulphonamides and fluoroquinolones) being wholly synthetic. The protective mechanisms that have evolved include preventing entry of or exporting the drug, producing enzymes
How does transmission of resistance occur between micro-organisms?
In addition to selection of antimicrobial resistance through mutations in genes encoded on a microbe's chromosome, new genetic material can also be exchanged between organisms. This process can provide the host cell and its progeny with new genetic material encoding antimicrobial resistance and can occur through several mechanisms, of which perhaps the most important is plasmid transmission (figure 1).15, 36, 37, 38, 39, 40 Antimicrobials influence this, not only by exerting a selective
Does antimicrobial resistance affect the fitness of micro-organisms?
There is a perception that antimicrobial-resistant microbes might be less fit (ie, less able to grow or cause an infection) than their antimicrobial susceptible counterparts. This situation would mean that reducing the burden of resistance might simply be achieved through removing the selective pressure of antimicrobials, leading to antimicrobial-resistant microbes losing out in darwinian competition with the susceptible strains. Unfortunately, this is frequently not the case and can be seen in
How should antimicrobials be used to preserve effectiveness and delay resistance in humans?
The published work on antimicrobial resistance across many different diseases converges on a remarkably consistent set of recommendations for prevention and containment.10, 20, 21, 22, 97, 98 These principles focus on improvement of diagnosis and prescription practices, reduction of antimicrobial use in animal husbandry, fish farming, agriculture, and environmental exposure in general, development of new antimicrobials, guarantee of access to essential medicines of assured quality, and
What gaps in our knowledge need addressing?
The need to address the research gaps in antimicrobial resistance has never been more keenly felt. However, identification of priorities, increase of research funding, and targeting research activity should be coordinated and cohesively addressed. The construction of a worldwide database of previous and present antimicrobial resistance projects has been advocated,102 but irrespective of this, several areas have particular priority.
First, understanding of how to minimise the selection of
Conclusion
Many of the drivers of antimicrobial resistance have a common origin in inappropriate use of antimicrobials in human and animal health care or in agriculture, or from environmental contamination. Although our understanding of antimicrobial resistance is far from complete, the existing evidence base is sufficient to allow targeted policies to be developed in several areas.2, 3, 4 Such strategies to reduce antimicrobial resistance should consider the role and effect of many factors, including the
References (119)
- et al.
Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success
Trends Microbiol
(2014) - et al.
Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
Lancet Infect Dis
(2011) Environmental pollution by antibiotics and by antibiotic resistance determinants
Environ Pollut
(2009)- et al.
Antibiotic resistance-the need for global solutions
Lancet Infect Dis
(2013) - et al.
Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial
Lancet
(2013) - et al.
Antibiotic use and resistance—proving the obvious
Lancet
(2005) Decrease in antibiotic use, an added benefit of PCVs
Lancet Infect Dis
(2014)- et al.
Use of antimicrobial agents in veterinary medicine and food animal production
Int J Antimicrob Agents
(2001) - et al.
The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria
Lancet Infect Dis
(2013) - et al.
Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study
Lancet Infect Dis
(2013)
Spatial and temporal analyses to investigate infectious disease transmission within healthcare settings
J Hosp Infect
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Lancet Infect Dis
Early (2008-2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK
Int J Antimicrob Agents
Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms
Drug Resist Updat
Impact of conjugate pneumococcal vaccines on antibiotic resistance
Lancet Infect Dis
Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction
Lancet
The effect of discontinuing the use of antimicrobial growth promoters on the productivity in the Danish broiler production
Prev Vet Med
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
Lancet
Factors affecting the reversal of antimicrobial-drug resistance
Lancet Infect Dis
Population biological principles of drug-resistance evolution in infectious diseases
Lancet Infect Dis
Time for action-Improving the design and reporting of behaviour change interventions for antimicrobial stewardship in hospitals: Early findings from a systematic review
Int J Antimicrob Agents
Access to effective antimicrobials: a worldwide challenge
Lancet
Maximising access access to achieve appropriate human antimicrobial use in low-income and middle-income countries
Lancet
Exploring the evidence base for national and regional policy interventions to combat resistance
Lancet
International cooperation to improve access to and sustain effectiveness of antimicrobials
Lancet
Bacterial phylogeny structures soil resistomes across habitats
Nature
The role of antibiotics and antibiotic resistance in nature
Environ Microbiol
The role of natural environments in the evolution of resistance traits in pathogenic bacteria
Proc R Soc Biol Sci
Microbiological effects of sublethal levels of antibiotics
Nat Rev Microbiol
Responses of Pseudomonas aeruginosa to antimicrobials
Front Microbiol
A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance
BMC Infect Dis
A review of antibiotic use in food animals: perspective, policy, and potential
Public Health Rep
Community acquisition of β-lactamase producing Enterobacteriaceae in neonatal gut
BMC Microbiol
Carbapenemase-producing organism in food, 2014
Emerg Infect Dis
In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase
Clin Infect Dis
Mutation and evolution of antibiotic resistance: antibiotics as promoters of antibiotic resistance?
Curr Drug Targets
Antibiotic resistance threats in the United States, 2013. Atlanta
The evolving threat of antimicrobial resistance: options for action. Geneva
Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals, 2011–2012. Stockholm
Surveillance of antimicrobial consumption in Europe 2012. Stockholm
Interventions to improve antibiotic prescribing practices in ambulatory care
Cochrane Database Syst Rev
Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
J Antimicrob Chemother
Interventions to improve antibiotic prescribing practices for hospital inpatients
Cochrane Database Syst Rev
Education of healthcare professionals and the public
J Antimicrob Chemother
Sales of veterinary antimicrobial agents in 25 EU/EEA countries. Third ESVAC report. London, 2013. doi:EMA/236501/2013
Survey of condition-based prescribing of antimicrobial drugs for dogs at a veterinary teaching hospital
Vet Rec
Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment
Environ Microbiol
Identification of diverse antimicrobial resistance determinants carried on bacterial, plasmid, or viral metagenomes from an activated sludge microbial assemblage
Appl Environ Microbiol
Bacteriophages carrying antibiotic resistance genes in fecal waste from cattle, pigs, and poultry
Antimicrob Agents Chemother
Cited by (1491)
Predicting antimicrobial resistance in E. coli with discriminative position fused deep learning classifier
2024, Computational and Structural Biotechnology JournalSolving the antibacterial resistance in Europe: The multipronged approach of the COST Action CA21145 EURESTOP
2024, Drug Resistance UpdatesUnveiling a novel mechanism for competitive advantage of ciprofloxacin-resistant bacteria in the environment through bacterial membrane vesicles
2024, Journal of Hazardous MaterialsCharacterising proximal and distal drivers of antimicrobial resistance: An umbrella review
2024, Journal of Global Antimicrobial Resistance